Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism

Journal of Immunology

Volumn 170, Issue 1, 2003, Pages 139-146

  Harizi, Hedi ^a   Juzan, Monique ^a   Moreau, Jean François ^a   Gualde, Norbert ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; ARACHIDONIC ACID; INTERLEUKIN 10; LEUKOTRIENE B4; PHOSPHOLIPASE A2; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION;

EID: 0037218334     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.1.139     Document Type: Article

References (57)

1. Funk, C. D. 2001. Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science 294:1871.
2. Byrum, B. S., J. L. Goulet, R. J. Griffits, and B. H. Koller. 1997. Role of 5-lipoxygenase-activating protein in murine acute inflammatory responses. J. Exp. Med. 17:1065.
3. Rosenbach, T., J. Czemielewski, M. Hecker, and B. Czarnetzki. 1990. Comparison of eicosanoid generation by highly purified human Langerhans cells and keratinocytes. J. Invest. Dermatol. 95:104.
4. 2 enhances the production of endogenous IL-10, which down-regulates the dendritic cell functions. J. Immunol. 168:2255.
5. Samulesson, B., S. E. Dahlen, J. A. Lindren, C. A. Rouzer, and N. C. Serhan, 1987. Leukotrienes and lipoxins: Structure, biosynthesis, and biological functions. Science 237:1171.
6. Mancini, J. A., M. Abramovitz, M. E. Cox, E. Wong, S. Charleson, H. Perrier, Z. Wang, P. Prasit, and P. J. Vickers. 1993. 5-Lipoxygenase-activating protein is an arachidonate binding protein. FEBS Lett. 318:277.
7. Abramovitz, M., M. E. Cox, E. Wong, C. D. Richardson, C. Li, and P. J. Vickers. 1993. 5-Lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase. Eur. J. Biochem. 215:105.
8. Woods, J. W., J. F. Evans, D. Ethier, S. Scott, P. J. Vickers, L. Hearn, J. A. Heilbein, S. Charleson, and I. I. Singler. 1993. 5-Lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 178:1935.
9. Woods, J. W., M. J. Coffey, T. G. Brock, I. I. Singler, and M. Peters-Golden. 1995. 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J. Clin. Invest. 95:2035.
10. Vickers, P. J. 1995. 5-Lipoxygenase-activating protein (FLAP). J. Lipid Mediators Cell Signaling 12:184.
11. 4. J. Biol. Chem. 264:19469.
12. Needelman, P., J. Turk, B. A. Takschik, A. R. Morrison, and J. B. Lefkowith. 1986. Arachidonic acid metabolism. Annu. Rev. Biochem. 55:69.
13. 4 hydrolase: Structure and functional properties in the active center. J. Lipid Mediators 6:1.
14. 4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286:264.
15. Rola-Pleszczynski, M. 1985. Immunoregulation by leukotrienes and other lipoxygenase metabolites. Immunol. Today 10:302.
16. Lewis, S. A., K. F. Austen, and R. J. Soberman. 1990. Leukotrienes and other products of the 5-LO pathway, biochemistry and relation to the pathobiology in human diseases. N. Engl. J. Med. 323:645.
17. Goetzl, E. J., and W. L. Smith. 1995. Specificity of expression and effect of eicosanoid mediators in normal physiology and human diseases. FASEB J. 9:1051.
18. Bailie, M. B., T. J. Standiford, L. L. Laichalk, M. J. Coffey, R. M. Strieter, and M. Peters-Golden. 1996. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumoniae in association with decreased alveolar macrophage phagocytic and bactericidal activities. J. Immunol. 157:5221.
19. Steinhilber, D. 1994. 5-Lipoxygenase: Enzyme expression and regulation of activity. Pharm. Acta Helv. 69:3.
20. Bennett, C. F., M.-Y. Chiang, B. P. Monia, and S. T. Crooke. 1993. Regulation of 5-lipoxygenase and 5-lipoxygenase-activating protein expression in HL-60 cells. Biochem. J. 289:33.
21. Nassar, G. M., A. Montero, M. Fukunaga, and K. F. Badr. 1997. Contrasting effects of proinflammatory and T-helper lymphocyte subset-2 cytokines on the 5-lipoxygenase pathway in monocytes. Kidney Int. 51:1520.
22. 4 synthesis by rat peritoneal macrophages. Br. J. Pharmacol. 96:265.
23. Chang, J., B. Lamb, L. Marinari, A. Kreft, and A. J. Lewis. 1985. Modulation by hydroxyeicosatetraenoic acid of arachidonic acid metabolism in mouse resident peritoneal macrophages. Eur. J. Pharmacol. 107:215.
24. Humes, J. L., E. E. Opas, M. Galavage, D. Soderman, and R. J. Bonney. 1986. Regulation of macrophage eicosanoid production by hydroperoxy and hydroeicosatetraenoic acid. Biochem. J. 233:199.
25. 2. Eur. J. Pharmacol. 114:71.
26. 4 release from activated neutrophils. Proc. Natl. Acad. Sci. USA 80:4349.
27. 4 synthesis in rat alveolar macrophages. J. Immunol. 151:2096.
28. + hematopoietic progenitors and in lymphoid organs. Blood 96:3857.
29. Spanbroek, R., H. J. Stark, U. Janssen-Timmen, S. Kraft, M. Hildner, T. Andl, F. X. Bosch, N. Fusenig, T. Bieber, O. Radmark, et al. 1998. 5-Lipoxygenase expression in Langerhans cells of normal human epidermis. Proc. Natl. Acad. Sci. USA 95:663.
30. Coffey, M. J., S. E. Wilcoxen, and M. Peters-Golden. 1994. Increases in 5-lipoxygenase-activating protein expression account for enhanced capacity of 5-lipoxygenase metabolism which accompanies differentiation of peripheral blood monocytes into alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 11:153.
31. Steinhilber, D., S. Hoshiko, J. Gunewald, O. Radmark, and B. Samuelsson. 1993. Serum factors regulate 5-lipoxygenase activity in maturing HL-60 cells. Biochim. Biophys. Acta 1178:1.
32. Mackenzie, R., G. A. Coles, N. Topley, W. S. Powell, and J. D. Williams. 1992. Down-regulation of cyclooxygenase product generation by human peritoneal macrophages. Immunology 76:648.
33. 4 excretion in aspirin-sensitive asthma. Am. J. Respir. Crit. Care Med. 53:572.
34. 2 that contributes to the immunomodulation induced by antigen-presenting cells. Cell. Immunol. 209:19.
35. You, Y., C. Y. A. Cheng, and A. B. Shyu. 1992. U-rich sequence-binding proteins (URBPs) interacting with a 20-nucleotide U-rich sequence in the 3′ untranslated region of c-fos mRNA may be involved in the first step of c-fos mRNA degradation. Mol. Cell. Biol. 12:2931.
36. Tilg, H., C. A. Dinarello, and J. W. Mier. 1997. IL-6 and APPs: Antiinflammatory and immunosuppressive mediators. Immunol. Today 18:428.
37. 2 to the nuclear fraction upon macrophage activation. Biochem. Biophys. Res. Commun. 196:147.
38. Dixon, R. A. F., R. E. Diehl, E. E. Opas, E. Rands, P. J. Vickers, J. F. Evans, J. W. Gillard, and D. K. Miller. 1990. Requirement of 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343:282.
39. Rouzer, C. A., A. W. Ford-Hutchinson, H. E. Morton, and J. W. Gillard. 1990. MK-886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-LO in ionophore challenged leukocytes. J. Biol. Chem. 265:1436.
40. Brock, T., R. W. McNish, and M. Peters-Golgen. 1998. Capacity for repeatable leukotriene generation after transient stimulation of mast cells and macrophages. Biochem. J. 319:519.
41. 4 enhances interleukin-6 production and IL-6 messenger accumulation in human monocytes in vitro: Transcriptional and post-transcriptional mechanisms. Blood 80:1004.
42. Goulet, J. L., J. N. Snouwaer, A. M. Latour, T. M. Coffman, and B. H. Koller. 1994. Altered inflammatory responses in leukotriene-deficient mice. Proc. Natl. Acad. Sci. USA 91:12852.
43. Burka, J. F., and N. A. M. Peterson. 1980. Evidence for lipoxygenase pathway involvement in allergic tracheal contraction. Prostaglandin 19:499.
44. Higgs, G. A., C. M. R. Bax, and S. Moncada. 1982. Advances in Prostaglandin, Thromboxane and Leukotriene Research, Vol. 9. B. Samuelsson and R. Paoletti, eds. Raven, New York, p. 331.
45. Walker, J. L. 1973. Advances in the Biosciences, Vol. 9. S. Bergstrom and S. Bernhard, eds. Pergamon, Elmsford, p. 235.
46. Bigby, T. D. 2002. The yin and the yang of 5-lipoxygenase pathway activation. Mol. Pharmacol. 62:200.
47. Peters-Golden, M., and T. G. Brock. 2000. Intracellular compartmentalization of leukotriene synthesis. Am. J. Respir. Crit. Care Med. 161:36.
48. 4 synthase expression by interleukin 4. J. Exp. Med. 193:123.
49. 4 synthesis accompanies adherence-dependent nuclear import of 5-lipoxygenase in human blood esinophils. J. Immunol. 162:1669.
50. Flammand, N., M. E. Surette, S. Picard, S. Bourgoin, and P. Bourgeat. 2002. cAMP-mediated inhibition of 5-lipoxygenase translocation and leukotriene biosynthesis in human neutrophils. Mol. Pharmacol. 62:250.
51. Kambayashi, T., P. A. R. Wallin, and H. G. Ljunggren. 2001. cAMP-elevating agents suppress dendritic cell function. J. Leukocyte Biol. 70:90.
52. 4 hydrolase by interleukin-4 and interleukin-13 in human polymorphonuclear leukocytes. Blood 96:601.
53. Fedyk, E. R., A. Adawi, R. J. Looney, and R. P. Phipps. 1996. Regulation of IgE and cytokine production by cAMP implications for extrinsic asthma. Clin. Immunol. Immunopathol. 81:101.
54. 2 on exercise induced bronchoconstriction in asthmatic subjects. Am. J. Respir. Crit. Care Med. 149:1138.
55. Szczeklik, A., L. Mastalerz, E. Nizankowska, and A. Cmiel. 1996. Protective and bronchodilatator effects of prostaglandin E and salbutamol in aspirin-induced asthma. Am. J. Respir. Crit. Care Med. 153:567.
56. Peebles, R. S., Jr., K. Hashimoto, J. D. Morrow, R. Drowski, R. D. Collins, Y. Hashimoto, J. W. Christman, K. H. Kang, K. Jarzeka, J. Furlong, et al. 2002. Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med. 165:1154.
57. Humes, J. L., S. Sadowski, M. Galavage, M. Goldenberg, E. Subers, R. J. Bonney, and F. A. Kuehl, Jr. 1982. Evidence for two sources of arachidonic acid for oxidative metabolism by mouse peritoneal macrophages. J. Biol. Chem. 257:1591.